HealthQuill Articles by: HealthQuill
Gram-negative, Chlamydia psittaci bacteria
Drugs Health Medical

Chlamydia vaccine shows promise in initial trials

HQ Team April 12, 2024: An early-stage clinical trial for a chlamydia vaccine has shown some positive results, according to a report published

Read More
About 45% of the US tap water contains one or more types of   “forever chemicals,” found in the linings of fast-food boxes and non-stick cookware to fire-fighting foams, raising health concerns, according to a US Geological Survey study.
Climate Health Medical

Study maps US, China, Australia as hotspots for ‘forever chemicals’ in water supplies

HQ Team April 10, 2024:  The Environmental Protection Agency in the US has regulated for the first time that municipal utilities will have

Read More
pollution
Climate Health Medical

57 companies responsible for 80% of recent world carbon emissions, says report

HQ Team April 10, 2024: A report released by the international non-profit InfluenceMap reveals that just 57 companies are responsible for 80 percent of the

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Medical Pharma

FDA’s accelerated approval of cancer drugs is hasty and doubtful, says new report

HQ Team April 10, 2024:  A new study has found that cancer drugs that got accelerated approval under the US Federal Drug Approval

Read More
Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with Elon Musk’s Neurolink.
Drugs Health Pharma

Rivalling Elon Musk’s Neurolink, Synchron plans brain implant trial 

HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with

Read More
Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to 59 years has met its primary goals in trials.
Drugs Health Pharma

Last-stage trials achieve “positive” results for RSV drug: Pfizer says

HQ Team April 9, 2024: Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to

Read More
endometriosis
Drugs Health Medical

Oral spray vaccine offers long-term relief against recurrent UTIs

HQ Team April 8, 2024: An oral spray vaccine has proved effective in halting recurrent Urinary Tract Infections (UTIs) for up to nine

Read More
The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.
Drugs Health Medical

Rapid cellular aging reason behind early-onset cancers: Scientists

HQ Team April 8, 2024: More cancer cases are being detected among the younger generation, according to a new study presented at the

Read More
Climate Health Pharma

PFAS found in leading brands of bandages, says report

HQ Team April 8, 2024: A study commissioned by the Environmental Health News and consumer watchdog site Mamavation, found that many bandage brands

Read More
Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the marketing authorisations for its amyotrophic lateral sclerosis (ALS) therapy after the drug failed in a last-stage trial.
Drugs Health Pharma

Amylyx Pharma pulls out ALS therapy drug from US, Canada

HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the

Read More